◆英語タイトル:Vaxil Bio Ltd (VXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9429
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit technology platform that enables integrated identification, isolation and production of antigen specific immunotherapies targeting high-profile cancer antigens. Vaxil Bio also develops Immucin, a lead immunotherapy product for multiple myeloma cancer patients. The company operates its laboratory in Ness-Ziona, Israel. Vaxil Bio is headquartered in Toronto, Ontario, Canada.
Vaxil Bio Ltd (VXL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vaxil Biotherapeutics To Raise US$3 Million In Venture Financing 11
Partnerships 12
Vaxil Bio Enters into Agreement with Clalit Meir Medical Center 12
Vaxil Bio Enters Agreement with Hadassah Medical Centre 13
Vaxil Bio Enters Into Research Agreement With University of Santiago de Compostela 14
Equity Offering 15
Vaxil Bio Raises USD1.4 Million in Private Placement of Shares and Warrants 15
Vaxil-Bio Raises USD0.5 Million in Private Placement of Units 16
Vaxil Bio Raises Funds through Private Placement of Shares 17
Vaxil Bio Raises Funds through Private Placement of Shares 18
Acquisition 19
Emerge Resources Acquires Vaxil Bio in Reverse Takeover Transaction 19
Vaxil Bio Ltd – Key Competitors 20
Vaxil Bio Ltd – Key Employees 21
Vaxil Bio Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Sep 06, 2018: Vaxil Appoints veteran pharma executive David Goren as CEO 23
Dec 05, 2017: Vaxil Strengthens Board of Directors and Management Concurrent to $1-Million Financing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List of Tables
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaxil Biotherapeutics To Raise US$3 Million In Venture Financing 11
Vaxil Bio Enters into Agreement with Clalit Meir Medical Center 12
Vaxil Bio Enters Agreement with Hadassah Medical Centre 13
Vaxil Bio Enters Into Research Agreement With University of Santiago de Compostela 14
Vaxil Bio Raises USD1.4 Million in Private Placement of Shares and Warrants 15
Vaxil-Bio Raises USD0.5 Million in Private Placement of Units 16
Vaxil Bio Raises Funds through Private Placement of Shares 17
Vaxil Bio Raises Funds through Private Placement of Shares 18
Emerge Resources Acquires Vaxil Bio in Reverse Takeover Transaction 19
Vaxil Bio Ltd, Key Competitors 20
Vaxil Bio Ltd, Key Employees 21
Vaxil Bio Ltd, Subsidiaries 22
List of Figures
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9